Leukemia Research
Volume 34, Issue 10 , Pages 1282-1286 , October 2010

The MIF −173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population

  • Yao Xue

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Nanjing Children's Hospital of Nanjing Medical University, No. 72 Guanzhou Road, Nanjing 210008, China
    • ,
  • Hongyan Xu

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Nanjing Children's Hospital of Nanjing Medical University, No. 72 Guanzhou Road, Nanjing 210008, China
    • ,
  • Liucheng Rong

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Nanjing Children's Hospital of Nanjing Medical University, No. 72 Guanzhou Road, Nanjing 210008, China
    • ,
  • Qin Lu

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Nanjing Children's Hospital of Nanjing Medical University, No. 72 Guanzhou Road, Nanjing 210008, China
    • ,
  • Jie Li

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Children's Hospital of Schoow University, Schoow, China
    • ,
  • Na Tong

      Affiliations

    • Department of Molecular and Genetic Toxicology, Cancer Center of Nanjing Medical University, Nanjing, China
    • ,
  • Meilin Wang

      Affiliations

    • Department of Molecular and Genetic Toxicology, Cancer Center of Nanjing Medical University, Nanjing, China
    • ,
  • Zhengdong Zhang

      Affiliations

    • Department of Molecular and Genetic Toxicology, Cancer Center of Nanjing Medical University, Nanjing, China
    • ,
  • Yongjun Fang

      Affiliations

    • Department of Hematology and Oncology, The Affiliated Nanjing Children's Hospital of Nanjing Medical University, No. 72 Guanzhou Road, Nanjing 210008, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 25 83117509; fax: +86 25 83304239.

Received 27 November 2009 ,Revised 26 February 2010 ,Accepted 17 March 2010.

References 

  1. Gallegos-Arreola MP, Batista-Gonzalez CM, Delgado-Lamas JL, Figuera LE, Puebla-Perez AM, Arnaud-Lopez L, et al. Cytochrome P4501A1 polymorphism is associated with susceptibility to acute lymphoblastic leukemia in adult Mexican patients. Blood Cells Mol Dis. 2004;33:326–329
  2. Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, et al. Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2019–2036
  3. Plasschaert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?. Cancer Treat Rev. 2004;30:37–51
  4. Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2000;38:447–462
  5. Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52:3020–3029
  6. Sanchez E, Gomez LM, Lopez-Nevot MA, Gonzalez-Gay MA, Sabio JM, Ortego-Centeno N, et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun. 2006;7:433–436
  7. Fei BY, Lv HX, Yang JM, Ye ZY. Association of MIF −173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine. 2008;41:44–47
  8. Oliver J, Marquez A, Gomez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, et al. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut. 2007;56:150–151
  9. Xia HH, Yang Y, Chu KM, Gu Q, Zhang YY, He H, et al. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer. 2009;
  10. Meyer-Siegler KL, Iczkowski KA, Vera PL. Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer. 2005;5:73
  11. Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008;261:147–157
  12. Kudrin A, Ray D. Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol. 2008;86:232–238
  13. Ding GX, Zhou SQ, Xu Z, Feng NH, Song NH, Wang XJ, et al. The association between MIF −173 G>C polymorphism and prostate cancer in southern Chinese. J Surg Oncol. 2009;100:106–110
  14. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol Rep. 2008;19:223–228
  15. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa. Int J Mol Med. 2009;24:563–569
  16. Chang YY, Greinix HT, Dickinson AM, Wolff D, Jackson GH, Andreesen R, et al. G to C transition at position −173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantation. Cytokine. 2009;48:218–225
  17. Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, Gregersen PK, et al. Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 2007;8:646–652
  18. Ziino O, D’Urbano LE, De Benedetti F, Conter V, Barisone E, De Rossi G, et al. The MIF −173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia. Leukemia. 2005;19:2346–2347
  19. Makhija R, Kingsnorth A, Demaine A. Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. Jop. 2007;8:289–295
  20. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D. Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology. 2002;13:277–281
  21. Freedman DM, Stewart P, Kleinerman RA, Wacholder S, Hatch EE, Tarone RE, et al. Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health. 2001;91:564–567
  22. Chang JS, Selvin S, Metayer C, Crouse V, Golembesky A, Buffler PA. Parental smoking and the risk of childhood leukemia. Am J Epidemiol. 2006;163:1091–1100
  23. Yeazel MW, Buckley JD, Woods WG, Ruccione K, Robison LL. History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the Childrens Cancer Group. Cancer. 1995;75:1718–1727
  24. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect. 2007;115:138–145
  25. Leaver SK, Maccallum NS, Pingle V, Hacking MB, Quinlan GJ, Evans TW, et al. Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor. Intensive Care Med. 2009;
  26. Sevketoglu E, Yilmaz A, Gedikbasi A, Karyagar S, Kiyak A, Mulazimoglu M, et al. Urinary macrophage migration inhibitory factor in children with urinary tract infection. Pediatr Nephrol. 2009;
  27. Rendon BE, Willer SS, Zundel W, Mitchell RA. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation. Exp Mol Pathol. 2009;86:180–185
  28. Fan T, Zhao Q, Chen JJ, Chen WT, Pearl ML. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol. 2009;112:185–191
  29. Petrenko O, Moll UM. Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell. 2005;17:225–236
  30. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2402–2409
  31. Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23:655–674
  32. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K, et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia. 2004;18:895–908
  33. Assuncao-Miranda I, Bozza MT, Da Poian AT. Pro-inflammatory response resulting from sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis. J Med Virol. 2010;82:164–174
  34. Wu J, Chen F, Zhang X, Li Y, Ma H, Zhou Y, et al. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China. J Dermatol Sci. 2009;53:212–215
  35. Fulda S. Cell death in hematological tumors. Apoptosis. 2009;14:409–423
  36. George RJ, Sturmoski MA, Anant S, Houchen CW. EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway. Prostaglandins Other Lipid Mediat. 2007;83:112–120
  37. Hou XQ, Gao YW, Yang ST, Wang CY, Ma ZY, Xia XZ. Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta Virol. 2009;53:225–231

PII: S0145-2126(10)00171-2

doi: 10.1016/j.leukres.2010.03.030

Leukemia Research
Volume 34, Issue 10 , Pages 1282-1286 , October 2010

Article Tools